Orion Oyj

Orion Oyj Series B
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
103.99 M
Public Float
-
Orion Oyj Series B
Stock Exchange Nasdaq Helsinki
EPS
EUR1.33
Market Cap
EUR4.72 B
Shares Outstanding
104.44 M
Public Float
100.7 M
Orion Oyj Series A
Stock Exchange Nasdaq Helsinki
EPS
EUR1.33
Market Cap
EUR4.69 B
Shares Outstanding
36.82 M
Public Float
24.6 M

Profile

Address
Orionintie 1A
Espoo UU 02200
Finland
Employees -
Website http://www.orion.fi
Updated 07/08/2019
Orion Oyj engages in the development of pharmaceutical and diagnostic test. It develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Its pharmaceutical research and development focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs.

Financials

View All

Heikki Seppo Westerlund
Chairman
Hilpi Rautelin
Director